

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.44883786 |
| 2 | neuronal action potential propagation (GO:0019227) | 5.43730755 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.22008515 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.14688483 |
| 5 | glutamate secretion (GO:0014047) | 4.84419979 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.71406492 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.56856116 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.50092015 |
| 9 | vocalization behavior (GO:0071625) | 4.32881634 |
| 10 | muscle filament sliding (GO:0030049) | 4.28269330 |
| 11 | actin-myosin filament sliding (GO:0033275) | 4.28269330 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17350851 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.17255894 |
| 14 | protein localization to synapse (GO:0035418) | 4.12387877 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.10347638 |
| 16 | regulation of cell communication by electrical coupling (GO:0010649) | 4.07787994 |
| 17 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.07661031 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 4.05515155 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.00154816 |
| 20 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.96799826 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.93408910 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.91679103 |
| 23 | exploration behavior (GO:0035640) | 3.89622283 |
| 24 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.88900442 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.88187290 |
| 26 | proline transport (GO:0015824) | 3.86007833 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.84189993 |
| 28 | sodium ion export (GO:0071436) | 3.80535028 |
| 29 | neuron cell-cell adhesion (GO:0007158) | 3.79174124 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.77701352 |
| 31 | membrane depolarization during action potential (GO:0086010) | 3.68245976 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 3.68239058 |
| 33 | neuromuscular process controlling posture (GO:0050884) | 3.66696561 |
| 34 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.65390003 |
| 35 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.60686061 |
| 36 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.59660258 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.59529871 |
| 38 | actin-mediated cell contraction (GO:0070252) | 3.55546480 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 3.54458605 |
| 40 | activation of protein kinase A activity (GO:0034199) | 3.53622395 |
| 41 | cerebellar granule cell differentiation (GO:0021707) | 3.47159058 |
| 42 | cell communication by electrical coupling (GO:0010644) | 3.47003783 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.46569275 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.45599110 |
| 45 | neuron-neuron synaptic transmission (GO:0007270) | 3.38164097 |
| 46 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.35401184 |
| 47 | layer formation in cerebral cortex (GO:0021819) | 3.31941967 |
| 48 | neurotransmitter transport (GO:0006836) | 3.29438916 |
| 49 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.29187605 |
| 50 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.27520654 |
| 51 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.27295599 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 3.27053591 |
| 53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24811131 |
| 54 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24717527 |
| 55 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.22115873 |
| 56 | regulation of vesicle fusion (GO:0031338) | 3.21090635 |
| 57 | cardiac muscle contraction (GO:0060048) | 3.20209882 |
| 58 | innervation (GO:0060384) | 3.19489348 |
| 59 | neuromuscular synaptic transmission (GO:0007274) | 3.19020356 |
| 60 | striated muscle contraction (GO:0006941) | 3.17967397 |
| 61 | neuromuscular process controlling balance (GO:0050885) | 3.16396802 |
| 62 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.11337146 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.09732038 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 3.09658112 |
| 65 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.08775278 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 3.08638825 |
| 67 | creatine metabolic process (GO:0006600) | 3.07274563 |
| 68 | vesicle transport along microtubule (GO:0047496) | 3.07273788 |
| 69 | potassium ion homeostasis (GO:0055075) | 3.05807197 |
| 70 | transmission of nerve impulse (GO:0019226) | 3.05366055 |
| 71 | skeletal muscle contraction (GO:0003009) | 3.04542218 |
| 72 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.04166188 |
| 73 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.03921564 |
| 74 | cell migration in hindbrain (GO:0021535) | 3.03852567 |
| 75 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03834731 |
| 76 | negative regulation of dendrite development (GO:2000171) | 3.03794739 |
| 77 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01953139 |
| 78 | long-term memory (GO:0007616) | 3.01243517 |
| 79 | mating behavior (GO:0007617) | 3.00017614 |
| 80 | detection of calcium ion (GO:0005513) | 2.99577261 |
| 81 | amino acid import (GO:0043090) | 2.98479639 |
| 82 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.97936920 |
| 83 | membrane depolarization (GO:0051899) | 2.97249450 |
| 84 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.96280508 |
| 85 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.96280508 |
| 86 | regulation of neurotransmitter transport (GO:0051588) | 2.94190768 |
| 87 | regulation of synapse maturation (GO:0090128) | 2.94082075 |
| 88 | detection of temperature stimulus (GO:0016048) | 2.92971334 |
| 89 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.92106395 |
| 90 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.91662817 |
| 91 | NADH metabolic process (GO:0006734) | 2.91617609 |
| 92 | regulation of postsynaptic membrane potential (GO:0060078) | 2.91584107 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91292122 |
| 94 | neuron recognition (GO:0008038) | 2.91248892 |
| 95 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.90135062 |
| 96 | neuronal action potential (GO:0019228) | 2.89651730 |
| 97 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.88735645 |
| 98 | potassium ion import (GO:0010107) | 2.88119385 |
| 99 | positive regulation of potassium ion transport (GO:0043268) | 2.88040964 |
| 100 | regulation of skeletal muscle contraction (GO:0014819) | 2.87657275 |
| 101 | neurofilament cytoskeleton organization (GO:0060052) | 2.86847572 |
| 102 | synaptic vesicle endocytosis (GO:0048488) | 2.86783695 |
| 103 | membrane repolarization (GO:0086009) | 2.86186599 |
| 104 | response to muscle activity (GO:0014850) | 2.85435417 |
| 105 | synaptic transmission (GO:0007268) | 2.85024074 |
| 106 | long-term synaptic potentiation (GO:0060291) | 2.84565490 |
| 107 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.84222102 |
| 108 | positive regulation of membrane potential (GO:0045838) | 2.83712300 |
| 109 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.83230514 |
| 110 | L-amino acid import (GO:0043092) | 2.81632970 |
| 111 | skeletal muscle fiber development (GO:0048741) | 2.81046253 |
| 112 | regulation of actin filament-based movement (GO:1903115) | 2.80457035 |
| 113 | regulation of glutamate secretion (GO:0014048) | 2.79878658 |
| 114 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.79435223 |
| 115 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.79435223 |
| 116 | axon cargo transport (GO:0008088) | 2.78993033 |
| 117 | neuromuscular process (GO:0050905) | 2.78899431 |
| 118 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.78550858 |
| 119 | calcium ion-dependent exocytosis (GO:0017156) | 2.77893223 |
| 120 | peptidyl-proline hydroxylation (GO:0019511) | 2.77767231 |
| 121 | cellular sodium ion homeostasis (GO:0006883) | 2.77636192 |
| 122 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.76156160 |
| 123 | organelle transport along microtubule (GO:0072384) | 2.75889908 |
| 124 | positive regulation of synapse maturation (GO:0090129) | 2.75518797 |
| 125 | plasma membrane repair (GO:0001778) | 2.75442707 |
| 126 | axonal fasciculation (GO:0007413) | 2.74895578 |
| 127 | regulation of relaxation of muscle (GO:1901077) | 2.74419166 |
| 128 | protein hydroxylation (GO:0018126) | 2.71175254 |
| 129 | protein retention in ER lumen (GO:0006621) | 2.66843482 |
| 130 | myofibril assembly (GO:0030239) | 2.65594461 |
| 131 | positive regulation of dendritic spine development (GO:0060999) | 2.64317293 |
| 132 | postsynaptic membrane organization (GO:0001941) | 2.61430232 |
| 133 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.60531573 |
| 134 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.60078293 |
| 135 | actin filament-based movement (GO:0030048) | 2.59433157 |
| 136 | daunorubicin metabolic process (GO:0044597) | 2.58525890 |
| 137 | polyketide metabolic process (GO:0030638) | 2.58525890 |
| 138 | doxorubicin metabolic process (GO:0044598) | 2.58525890 |
| 139 | neurotransmitter uptake (GO:0001504) | 2.56950340 |
| 140 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.56793039 |
| 141 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.56793039 |
| 142 | cardiac myofibril assembly (GO:0055003) | 2.55382171 |
| 143 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.52590674 |
| 144 | gluconeogenesis (GO:0006094) | 2.51575432 |
| 145 | cell communication involved in cardiac conduction (GO:0086065) | 2.51366099 |
| 146 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.50327226 |
| 147 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.50079572 |
| 148 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49351774 |
| 149 | muscle cell cellular homeostasis (GO:0046716) | 2.49255509 |
| 150 | phosphate ion transmembrane transport (GO:0035435) | 2.47548658 |
| 151 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.46737728 |
| 152 | muscle contraction (GO:0006936) | 2.45323918 |
| 153 | neuronal ion channel clustering (GO:0045161) | 2.45168839 |
| 154 | relaxation of muscle (GO:0090075) | 2.40666658 |
| 155 | sarcomere organization (GO:0045214) | 2.39865481 |
| 156 | myotube cell development (GO:0014904) | 2.39490887 |
| 157 | negative regulation of protein localization to cell surface (GO:2000009) | 2.36721050 |
| 158 | axon ensheathment in central nervous system (GO:0032291) | 2.36711846 |
| 159 | central nervous system myelination (GO:0022010) | 2.36711846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75927425 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.10398553 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.43029207 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.32261895 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25273015 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.23438352 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.96341098 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.96341098 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.95554662 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.84512184 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.84442956 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79825829 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.75775693 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.72641764 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.66222604 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.59975376 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.58986783 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.55716770 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52715653 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.52481080 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44600209 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.40826982 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.32615059 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24820219 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24002091 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22365708 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22086699 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18595524 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15877182 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98660670 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95700154 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94948324 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.86267778 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85788219 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.82745292 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81366284 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.75713708 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71681538 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71289009 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66922190 |
| 41 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.65999401 |
| 42 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.65999401 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65767971 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.65153820 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61624495 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59656005 |
| 47 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58330074 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56216352 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56104581 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55579957 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46691343 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40191053 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39080677 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35768731 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34473844 |
| 56 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33245222 |
| 57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33134894 |
| 58 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32993116 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29713925 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27547418 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27430356 |
| 62 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27227147 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26429365 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26048858 |
| 65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24870308 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24322907 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23393866 |
| 68 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22227596 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21561304 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20600986 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19694820 |
| 72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19678029 |
| 73 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19554360 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19149839 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18914168 |
| 76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17784679 |
| 77 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17069187 |
| 78 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.16702942 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16338455 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16185574 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12844275 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11711199 |
| 83 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11441434 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11273351 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11196596 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11196596 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10442648 |
| 88 | AR_19668381_ChIP-Seq_PC3_Human | 1.09793080 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09543383 |
| 90 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09104726 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08723344 |
| 92 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.07899594 |
| 93 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.07587346 |
| 94 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06297551 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06182820 |
| 96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05460954 |
| 97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04366618 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03795310 |
| 99 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02999329 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02928236 |
| 101 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01849401 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01219788 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00967965 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00472989 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98268811 |
| 106 | JUN_21703547_ChIP-Seq_K562_Human | 0.98175339 |
| 107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98151836 |
| 108 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97818465 |
| 109 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97433671 |
| 110 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97151381 |
| 111 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96636832 |
| 112 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96397646 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96167802 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95959366 |
| 115 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95452513 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94989324 |
| 117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94770805 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94044292 |
| 119 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93259881 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92843223 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92275612 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92259841 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92214394 |
| 124 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91443232 |
| 125 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91355390 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90626637 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90496954 |
| 128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90218088 |
| 129 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89754679 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89676406 |
| 131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87605427 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87573232 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87238491 |
| 134 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86546500 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.86431978 |
| 136 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86188375 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85529260 |
| 138 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85189803 |
| 139 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.84985543 |
| 140 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84075537 |
| 141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84061497 |
| 142 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83848738 |
| 143 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83659016 |
| 144 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83612736 |
| 145 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83476478 |
| 146 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.83389562 |
| 147 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81782020 |
| 148 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81484157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.44025756 |
| 2 | MP0003880_abnormal_central_pattern | 4.08404433 |
| 3 | MP0004270_analgesia | 3.83280195 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.80266269 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.57061399 |
| 6 | MP0002735_abnormal_chemical_nociception | 3.30900802 |
| 7 | MP0002736_abnormal_nociception_after | 3.18262945 |
| 8 | MP0009745_abnormal_behavioral_response | 2.99547851 |
| 9 | MP0009046_muscle_twitch | 2.96418472 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.83385374 |
| 11 | MP0002064_seizures | 2.81877131 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.80818032 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.72531085 |
| 14 | MP0004858_abnormal_nervous_system | 2.58632003 |
| 15 | MP0002272_abnormal_nervous_system | 2.58568507 |
| 16 | MP0002733_abnormal_thermal_nociception | 2.48864080 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.40162061 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.35337273 |
| 19 | MP0002822_catalepsy | 2.34276910 |
| 20 | MP0000751_myopathy | 2.33332830 |
| 21 | MP0001970_abnormal_pain_threshold | 2.28074162 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.09736484 |
| 23 | MP0003329_amyloid_beta_deposits | 2.07492546 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.04350255 |
| 25 | MP0002067_abnormal_sensory_capabilities | 2.03864408 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.03330686 |
| 27 | MP0001486_abnormal_startle_reflex | 1.99685656 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.87865298 |
| 29 | MP0008569_lethality_at_weaning | 1.85913721 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.82554516 |
| 31 | MP0002184_abnormal_innervation | 1.80552394 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.62307053 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.60510338 |
| 34 | MP0003122_maternal_imprinting | 1.54889000 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.53777699 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.53629115 |
| 37 | MP0004924_abnormal_behavior | 1.53629115 |
| 38 | MP0000955_abnormal_spinal_cord | 1.53566519 |
| 39 | MP0005330_cardiomyopathy | 1.51931734 |
| 40 | MP0004142_abnormal_muscle_tone | 1.49981405 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.48908809 |
| 42 | MP0004272_abnormal_basement_membrane | 1.48889063 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.48432739 |
| 44 | MP0001958_emphysema | 1.48270274 |
| 45 | MP0000749_muscle_degeneration | 1.48094230 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.40059441 |
| 47 | MP0000747_muscle_weakness | 1.39626252 |
| 48 | MP0001984_abnormal_olfaction | 1.38734231 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.36734122 |
| 50 | MP0003690_abnormal_glial_cell | 1.33798163 |
| 51 | MP0001905_abnormal_dopamine_level | 1.33570294 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.33065487 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.29492849 |
| 54 | MP0003633_abnormal_nervous_system | 1.26700114 |
| 55 | MP0005451_abnormal_body_composition | 1.26679465 |
| 56 | MP0002882_abnormal_neuron_morphology | 1.26660330 |
| 57 | MP0002972_abnormal_cardiac_muscle | 1.25737860 |
| 58 | MP0000778_abnormal_nervous_system | 1.22798888 |
| 59 | MP0003646_muscle_fatigue | 1.21617747 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.21416079 |
| 61 | MP0001529_abnormal_vocalization | 1.20686803 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.19317579 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.18931807 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.17610444 |
| 65 | MP0003950_abnormal_plasma_membrane | 1.16925302 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.15457302 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.12589553 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.09994930 |
| 69 | MP0004036_abnormal_muscle_relaxation | 1.09550557 |
| 70 | MP0003631_nervous_system_phenotype | 1.06888570 |
| 71 | MP0005165_increased_susceptibility_to | 1.06551806 |
| 72 | MP0000733_abnormal_muscle_development | 1.05806945 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.05422735 |
| 74 | MP0003879_abnormal_hair_cell | 1.04956669 |
| 75 | MP0002971_abnormal_brown_adipose | 1.03747783 |
| 76 | MP0001299_abnormal_eye_distance/ | 1.00639955 |
| 77 | MP0001177_atelectasis | 1.00502179 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 0.99613736 |
| 79 | MP0005670_abnormal_white_adipose | 0.99380139 |
| 80 | MP0001502_abnormal_circadian_rhythm | 0.99234816 |
| 81 | MP0004147_increased_porphyrin_level | 0.98985087 |
| 82 | MP0003279_aneurysm | 0.98350284 |
| 83 | MP0005375_adipose_tissue_phenotype | 0.97203715 |
| 84 | MP0004885_abnormal_endolymph | 0.96667588 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.96116825 |
| 86 | MP0004233_abnormal_muscle_weight | 0.95771619 |
| 87 | MP0006138_congestive_heart_failure | 0.95176841 |
| 88 | MP0010630_abnormal_cardiac_muscle | 0.92889810 |
| 89 | MP0003634_abnormal_glial_cell | 0.90934995 |
| 90 | MP0000604_amyloidosis | 0.89661086 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.87981843 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.87811294 |
| 93 | MP0002229_neurodegeneration | 0.87765262 |
| 94 | MP0008872_abnormal_physiological_respon | 0.87708481 |
| 95 | MP0005275_abnormal_skin_tensile | 0.84986430 |
| 96 | MP0004484_altered_response_of | 0.84940913 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.84848268 |
| 98 | MP0001188_hyperpigmentation | 0.84436317 |
| 99 | MP0002152_abnormal_brain_morphology | 0.83468010 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.82263330 |
| 101 | MP0004085_abnormal_heartbeat | 0.81492058 |
| 102 | MP0001542_abnormal_bone_strength | 0.81443156 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.81355896 |
| 104 | MP0008874_decreased_physiological_sensi | 0.81072982 |
| 105 | MP0005620_abnormal_muscle_contractility | 0.80434607 |
| 106 | MP0006036_abnormal_mitochondrial_physio | 0.79512068 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.79220395 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 0.78397365 |
| 109 | MP0002269_muscular_atrophy | 0.77910738 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.77147294 |
| 111 | MP0004510_myositis | 0.76347134 |
| 112 | MP0000920_abnormal_myelination | 0.75877010 |
| 113 | MP0001544_abnormal_cardiovascular_syste | 0.75682681 |
| 114 | MP0005385_cardiovascular_system_phenoty | 0.75682681 |
| 115 | MP0005369_muscle_phenotype | 0.73394757 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.72732446 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.72656528 |
| 118 | MP0003632_abnormal_nervous_system | 0.71746884 |
| 119 | MP0002108_abnormal_muscle_morphology | 0.70652325 |
| 120 | MP0002106_abnormal_muscle_physiology | 0.70280312 |
| 121 | MP0004130_abnormal_muscle_cell | 0.69600298 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.68298930 |
| 123 | MP0003075_altered_response_to | 0.68089840 |
| 124 | MP0005171_absent_coat_pigmentation | 0.67526197 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.66680361 |
| 126 | MP0005503_abnormal_tendon_morphology | 0.64111119 |
| 127 | MP0005535_abnormal_body_temperature | 0.63798443 |
| 128 | MP0000534_abnormal_ureter_morphology | 0.62876895 |
| 129 | MP0001664_abnormal_digestion | 0.61603650 |
| 130 | MP0002751_abnormal_autonomic_nervous | 0.61424151 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.61071824 |
| 132 | MP0003283_abnormal_digestive_organ | 0.61070039 |
| 133 | MP0003787_abnormal_imprinting | 0.60993412 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.59781573 |
| 135 | MP0002638_abnormal_pupillary_reflex | 0.59151643 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.57970104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.72730131 |
| 2 | Focal motor seizures (HP:0011153) | 6.60163293 |
| 3 | Focal seizures (HP:0007359) | 4.97143408 |
| 4 | Atonic seizures (HP:0010819) | 4.61547276 |
| 5 | Visual hallucinations (HP:0002367) | 4.33648791 |
| 6 | Action tremor (HP:0002345) | 4.32820194 |
| 7 | Febrile seizures (HP:0002373) | 4.00088251 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.78740759 |
| 9 | Absence seizures (HP:0002121) | 3.77755420 |
| 10 | Pheochromocytoma (HP:0002666) | 3.56989126 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.55482997 |
| 12 | Round ear (HP:0100830) | 3.51009757 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.48714124 |
| 14 | Dialeptic seizures (HP:0011146) | 3.41865055 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.39164838 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.28703146 |
| 17 | Neuroendocrine neoplasm (HP:0100634) | 3.28178577 |
| 18 | Myoglobinuria (HP:0002913) | 3.18699457 |
| 19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.16140043 |
| 20 | Ankle clonus (HP:0011448) | 3.12315155 |
| 21 | Myotonia (HP:0002486) | 3.10425774 |
| 22 | Neck muscle weakness (HP:0000467) | 3.04104849 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.02906759 |
| 24 | Sudden death (HP:0001699) | 2.99040989 |
| 25 | Ulnar claw (HP:0001178) | 2.98178131 |
| 26 | Exercise-induced myalgia (HP:0003738) | 2.97947377 |
| 27 | Depression (HP:0000716) | 2.92799561 |
| 28 | Insidious onset (HP:0003587) | 2.87696596 |
| 29 | Termporal pattern (HP:0011008) | 2.87696596 |
| 30 | Ulnar deviation of the wrist (HP:0003049) | 2.86527672 |
| 31 | Truncal ataxia (HP:0002078) | 2.85980476 |
| 32 | Anxiety (HP:0000739) | 2.85843616 |
| 33 | Muscle fiber splitting (HP:0003555) | 2.77129388 |
| 34 | Myopathic facies (HP:0002058) | 2.76732447 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.71109639 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 2.58701494 |
| 37 | Urinary urgency (HP:0000012) | 2.57225359 |
| 38 | Increased connective tissue (HP:0009025) | 2.53902368 |
| 39 | Difficulty running (HP:0009046) | 2.53184401 |
| 40 | Arterial tortuosity (HP:0005116) | 2.53094141 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 2.52464385 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.52394529 |
| 43 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.49524394 |
| 44 | Distal arthrogryposis (HP:0005684) | 2.48405080 |
| 45 | Abnormal eating behavior (HP:0100738) | 2.46300050 |
| 46 | Dysmetria (HP:0001310) | 2.45534494 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.44532635 |
| 48 | Hypoventilation (HP:0002791) | 2.42097942 |
| 49 | Vascular tortuosity (HP:0004948) | 2.41634652 |
| 50 | Amblyopia (HP:0000646) | 2.41446030 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.38925790 |
| 52 | Impaired pain sensation (HP:0007328) | 2.37827440 |
| 53 | Abnormality of pain sensation (HP:0010832) | 2.37827440 |
| 54 | Poor eye contact (HP:0000817) | 2.37149766 |
| 55 | Calcaneovalgus deformity (HP:0001848) | 2.37089528 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.36758110 |
| 57 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.31721811 |
| 58 | Broad-based gait (HP:0002136) | 2.29341802 |
| 59 | Postural instability (HP:0002172) | 2.29338201 |
| 60 | Progressive inability to walk (HP:0002505) | 2.26881165 |
| 61 | Scanning speech (HP:0002168) | 2.25628505 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.25061476 |
| 63 | Subaortic stenosis (HP:0001682) | 2.25061476 |
| 64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24117599 |
| 65 | Exercise-induced muscle cramps (HP:0003710) | 2.23803663 |
| 66 | Megalencephaly (HP:0001355) | 2.22885964 |
| 67 | Muscle stiffness (HP:0003552) | 2.22864911 |
| 68 | Absent phalangeal crease (HP:0006109) | 2.19629643 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.19534711 |
| 70 | Abnormal atrioventricular conduction (HP:0005150) | 2.18695296 |
| 71 | Back pain (HP:0003418) | 2.18671994 |
| 72 | Muscle fiber inclusion bodies (HP:0100299) | 2.18647438 |
| 73 | Impaired social interactions (HP:0000735) | 2.18427414 |
| 74 | Abnormal social behavior (HP:0012433) | 2.18427414 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.17810034 |
| 76 | Akinesia (HP:0002304) | 2.16713837 |
| 77 | Bradykinesia (HP:0002067) | 2.13581621 |
| 78 | Torticollis (HP:0000473) | 2.13402260 |
| 79 | Heart block (HP:0012722) | 2.12798341 |
| 80 | Frequent falls (HP:0002359) | 2.11985399 |
| 81 | Delusions (HP:0000746) | 2.11373152 |
| 82 | Malignant hyperthermia (HP:0002047) | 2.10923421 |
| 83 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10907918 |
| 84 | Hypercortisolism (HP:0001578) | 2.10619482 |
| 85 | Type 1 muscle fiber predominance (HP:0003803) | 2.09616627 |
| 86 | Spastic gait (HP:0002064) | 2.09565752 |
| 87 | Gowers sign (HP:0003391) | 2.07989391 |
| 88 | Spinal rigidity (HP:0003306) | 2.07938742 |
| 89 | Hammertoe (HP:0001765) | 2.07762046 |
| 90 | Deformed tarsal bones (HP:0008119) | 2.07126690 |
| 91 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06991331 |
| 92 | Scapular winging (HP:0003691) | 2.06704063 |
| 93 | Abnormality of binocular vision (HP:0011514) | 2.06060412 |
| 94 | Diplopia (HP:0000651) | 2.06060412 |
| 95 | Menstrual irregularities (HP:0000858) | 2.05842058 |
| 96 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.05041002 |
| 97 | Lower limb muscle weakness (HP:0007340) | 2.01876870 |
| 98 | Focal dystonia (HP:0004373) | 2.01366706 |
| 99 | Limb dystonia (HP:0002451) | 2.01360190 |
| 100 | Rimmed vacuoles (HP:0003805) | 2.01338641 |
| 101 | Distal lower limb amyotrophy (HP:0008944) | 2.01001861 |
| 102 | Papilledema (HP:0001085) | 1.99507408 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 1.98976172 |
| 104 | Mitral stenosis (HP:0001718) | 1.98572966 |
| 105 | Rapidly progressive (HP:0003678) | 1.98546925 |
| 106 | Retinal dysplasia (HP:0007973) | 1.98353552 |
| 107 | Atrioventricular block (HP:0001678) | 1.97433527 |
| 108 | Breech presentation (HP:0001623) | 1.95977969 |
| 109 | Premature rupture of membranes (HP:0001788) | 1.95571843 |
| 110 | Calf muscle hypertrophy (HP:0008981) | 1.93592219 |
| 111 | Abnormality of the lower motor neuron (HP:0002366) | 1.93573215 |
| 112 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93497627 |
| 113 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.91564121 |
| 114 | Rigidity (HP:0002063) | 1.91560136 |
| 115 | EMG: neuropathic changes (HP:0003445) | 1.91106381 |
| 116 | Insomnia (HP:0100785) | 1.90343785 |
| 117 | Steppage gait (HP:0003376) | 1.90162973 |
| 118 | Hemiparesis (HP:0001269) | 1.89486577 |
| 119 | Nemaline bodies (HP:0003798) | 1.88685016 |
| 120 | Abnormality of glycolysis (HP:0004366) | 1.87870300 |
| 121 | Bundle branch block (HP:0011710) | 1.87687274 |
| 122 | Mutism (HP:0002300) | 1.87365053 |
| 123 | Abnormality of the calf musculature (HP:0001430) | 1.87211580 |
| 124 | Wormian bones (HP:0002645) | 1.86697085 |
| 125 | Craniofacial dystonia (HP:0012179) | 1.85678044 |
| 126 | Type II lissencephaly (HP:0007260) | 1.85384414 |
| 127 | Limb-girdle muscle atrophy (HP:0003797) | 1.85159027 |
| 128 | Deep venous thrombosis (HP:0002625) | 1.85018770 |
| 129 | Aplasia involving bones of the extremities (HP:0009825) | 1.84238633 |
| 130 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.84238633 |
| 131 | Aplasia of the phalanges of the hand (HP:0009802) | 1.84238633 |
| 132 | Hyporeflexia of lower limbs (HP:0002600) | 1.83769274 |
| 133 | Shoulder girdle muscle weakness (HP:0003547) | 1.83612013 |
| 134 | Neurofibrillary tangles (HP:0002185) | 1.82596760 |
| 135 | Abnormality of the foot musculature (HP:0001436) | 1.82560658 |
| 136 | Postural tremor (HP:0002174) | 1.81665442 |
| 137 | Resting tremor (HP:0002322) | 1.81575685 |
| 138 | Psychosis (HP:0000709) | 1.81179396 |
| 139 | Narrow nasal bridge (HP:0000446) | 1.81058617 |
| 140 | Cerebral inclusion bodies (HP:0100314) | 1.80604089 |
| 141 | Impaired smooth pursuit (HP:0007772) | 1.80440895 |
| 142 | Hemiplegia (HP:0002301) | 1.79716704 |
| 143 | Intention tremor (HP:0002080) | 1.79647907 |
| 144 | EMG: myopathic abnormalities (HP:0003458) | 1.78224708 |
| 145 | Abnormality of the corticospinal tract (HP:0002492) | 1.78056020 |
| 146 | Lower limb amyotrophy (HP:0007210) | 1.77694098 |
| 147 | Cerebral aneurysm (HP:0004944) | 1.76501136 |
| 148 | Aortic aneurysm (HP:0004942) | 1.75623967 |
| 149 | Increased serum pyruvate (HP:0003542) | 1.73728435 |
| 150 | Tetraplegia (HP:0002445) | 1.69990587 |
| 151 | Aortic dissection (HP:0002647) | 1.69625747 |
| 152 | Areflexia of lower limbs (HP:0002522) | 1.67804531 |
| 153 | Metatarsus adductus (HP:0001840) | 1.66016230 |
| 154 | Abnormal finger flexion creases (HP:0006143) | 1.63771295 |
| 155 | Lipoatrophy (HP:0100578) | 1.62164916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.67465349 |
| 2 | MAP3K9 | 3.71151689 |
| 3 | EPHA4 | 3.10650419 |
| 4 | MINK1 | 2.98827655 |
| 5 | MAP3K12 | 2.70927233 |
| 6 | KSR2 | 2.70627754 |
| 7 | MAP3K4 | 2.68036950 |
| 8 | NTRK1 | 2.62060857 |
| 9 | MAP2K4 | 2.26531283 |
| 10 | PHKG2 | 2.25298839 |
| 11 | PHKG1 | 2.25298839 |
| 12 | PAK6 | 2.22502785 |
| 13 | MAP2K7 | 2.20691466 |
| 14 | ARAF | 2.17015299 |
| 15 | LMTK2 | 2.11725724 |
| 16 | RIPK1 | 2.05417056 |
| 17 | TESK1 | 1.84319807 |
| 18 | DAPK2 | 1.75600054 |
| 19 | RIPK4 | 1.69946844 |
| 20 | PRKD3 | 1.65052740 |
| 21 | GRK5 | 1.63872911 |
| 22 | CAMKK1 | 1.57218022 |
| 23 | LATS2 | 1.54030961 |
| 24 | NTRK2 | 1.45992032 |
| 25 | CASK | 1.45063381 |
| 26 | CAMKK2 | 1.41770914 |
| 27 | MARK1 | 1.40944184 |
| 28 | CDK19 | 1.38384053 |
| 29 | KSR1 | 1.37540067 |
| 30 | PDGFRA | 1.36397745 |
| 31 | CDK5 | 1.36386369 |
| 32 | PLK2 | 1.35679329 |
| 33 | MAP3K2 | 1.27610374 |
| 34 | NEK9 | 1.25968607 |
| 35 | RET | 1.21292726 |
| 36 | PRKCG | 1.17224752 |
| 37 | MAP3K13 | 1.16698894 |
| 38 | PINK1 | 1.12794288 |
| 39 | RAF1 | 1.11370652 |
| 40 | CCNB1 | 1.10492514 |
| 41 | NME1 | 1.09872823 |
| 42 | NEK1 | 1.09523906 |
| 43 | BCKDK | 1.09438179 |
| 44 | SCYL2 | 1.07685745 |
| 45 | DAPK1 | 1.04155204 |
| 46 | TNIK | 1.01989361 |
| 47 | MAPK13 | 0.99817100 |
| 48 | UHMK1 | 0.98084217 |
| 49 | PAK2 | 0.96586218 |
| 50 | PNCK | 0.96397685 |
| 51 | OBSCN | 0.95576721 |
| 52 | CAMK2A | 0.95365022 |
| 53 | PAK3 | 0.94588871 |
| 54 | STK38 | 0.94559080 |
| 55 | LIMK1 | 0.93632690 |
| 56 | ICK | 0.93394835 |
| 57 | CDK14 | 0.92937112 |
| 58 | PTK2B | 0.91661915 |
| 59 | FER | 0.89093837 |
| 60 | PIM2 | 0.89027866 |
| 61 | DAPK3 | 0.88399567 |
| 62 | MAP3K1 | 0.88375905 |
| 63 | MAPKAPK5 | 0.88331061 |
| 64 | CDK18 | 0.86134213 |
| 65 | MUSK | 0.85459006 |
| 66 | CDK15 | 0.84451676 |
| 67 | SGK223 | 0.81762677 |
| 68 | SGK494 | 0.81762677 |
| 69 | MAP2K1 | 0.81413200 |
| 70 | CAMK2G | 0.80026754 |
| 71 | MST1R | 0.78180193 |
| 72 | WNK1 | 0.77243594 |
| 73 | PKN1 | 0.76856227 |
| 74 | ERN1 | 0.74939806 |
| 75 | TNK2 | 0.74622331 |
| 76 | CDK11A | 0.74344404 |
| 77 | ABL2 | 0.72562314 |
| 78 | MET | 0.72474567 |
| 79 | CAMK1 | 0.71907146 |
| 80 | AKT2 | 0.70307905 |
| 81 | MAPK11 | 0.69707412 |
| 82 | CAMK2B | 0.69392753 |
| 83 | DDR2 | 0.68714770 |
| 84 | TAOK1 | 0.67079962 |
| 85 | ERBB4 | 0.66783463 |
| 86 | PRPF4B | 0.66434723 |
| 87 | PRKCH | 0.65740155 |
| 88 | TAOK2 | 0.65225298 |
| 89 | TYRO3 | 0.63676275 |
| 90 | MOS | 0.62944841 |
| 91 | MYLK | 0.62865384 |
| 92 | MAPK10 | 0.62842819 |
| 93 | FES | 0.62281772 |
| 94 | ADRBK1 | 0.61117683 |
| 95 | PDPK1 | 0.58746540 |
| 96 | CAMK2D | 0.58442167 |
| 97 | PTK2 | 0.58056618 |
| 98 | GRK7 | 0.56523753 |
| 99 | SGK2 | 0.56521713 |
| 100 | MARK2 | 0.56304238 |
| 101 | ROCK2 | 0.55900437 |
| 102 | PDK1 | 0.55434559 |
| 103 | DMPK | 0.52587221 |
| 104 | TRIB3 | 0.52560044 |
| 105 | TTN | 0.51383419 |
| 106 | CSNK1G2 | 0.49255437 |
| 107 | CDK8 | 0.47902084 |
| 108 | SIK2 | 0.47466628 |
| 109 | MAPK4 | 0.47352280 |
| 110 | TGFBR2 | 0.47217766 |
| 111 | BRAF | 0.46793892 |
| 112 | PRKCE | 0.46298521 |
| 113 | SGK1 | 0.46031315 |
| 114 | PDK4 | 0.45714116 |
| 115 | PDK3 | 0.45714116 |
| 116 | MAP3K7 | 0.45632672 |
| 117 | FGFR4 | 0.45595463 |
| 118 | OXSR1 | 0.45261119 |
| 119 | CAMK4 | 0.44917229 |
| 120 | MATK | 0.44408489 |
| 121 | SGK3 | 0.42356896 |
| 122 | EEF2K | 0.42108983 |
| 123 | MAPKAPK3 | 0.40599469 |
| 124 | RPS6KA3 | 0.39073761 |
| 125 | STK11 | 0.38558043 |
| 126 | ROCK1 | 0.38540419 |
| 127 | MAPK12 | 0.38173994 |
| 128 | RPS6KA2 | 0.37815570 |
| 129 | MAP3K11 | 0.36916347 |
| 130 | PIK3CG | 0.35980755 |
| 131 | PRKG1 | 0.35247223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.32337282 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.13522530 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63852318 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.56447438 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50154398 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45476051 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45295568 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.43267085 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36526714 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35295338 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.22406050 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21696152 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.07531568 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05827194 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 2.05352205 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.02437512 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.97662170 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91312848 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87052084 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.79082821 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76459070 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.72095422 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.70475426 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67901451 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.66667051 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65608278 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64915492 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63872629 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.63776607 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.63515750 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59646352 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.54651926 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53164084 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.50201131 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40794532 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.39372850 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.38740643 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.37593546 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34903213 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34689410 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33673963 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.32971900 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.25365724 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25151570 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24666259 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21994701 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21904415 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20361055 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20297604 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20273338 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18534161 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17950994 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.16711969 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.14982459 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12584922 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11783631 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 1.11281966 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08193741 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.06166213 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04105799 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03190962 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02845726 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98530871 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96085942 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95587404 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95241954 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94698634 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93322023 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92400683 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92284679 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91550072 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88779542 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.87803609 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87439806 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81977354 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80652033 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79089722 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77512832 |
| 79 | Axon guidance_Homo sapiens_hsa04360 | 0.77432012 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76262853 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75545419 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75268796 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75195761 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74580984 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73246583 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73194137 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72288412 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70805442 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70065467 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69640175 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69592048 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68950612 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68064993 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67124527 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65119739 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64372922 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61902755 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60867590 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60605147 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59360505 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58930492 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57124265 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56742404 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55734911 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54423331 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54007502 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50478357 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49208161 |
| 109 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49148630 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48347143 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48113218 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48111036 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.47718450 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47239824 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45926394 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.44918433 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.43811359 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42233226 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40727901 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.39652926 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39372857 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39332366 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37571066 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35865735 |
| 125 | Melanoma_Homo sapiens_hsa05218 | 0.35751132 |
| 126 | Phototransduction_Homo sapiens_hsa04744 | 0.35617596 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35492990 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35183957 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33968791 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33683514 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33149662 |
| 132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32730710 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32282137 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32135258 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31303399 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29001327 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28430396 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25825407 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24948070 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24613189 |

